PFAS chemicals in firefighting foam have been linked to liver disease and liver cancer
Multiple research studies have found a connection between PFAS chemicals, which are detectable in legacy AFFF stocks. One study found that elevated levels of certain PFAS types can lead to an increased risk of developing HCC. They found that people with higher concentrations of PFOS (a specific type of PFAS chemical) in their blood are 4.5 times more likely to develop HCC.
In another study, authors found that higher concentrations of PFAS in the bloodstream can increase the risk of non-alcoholic fatty liver disease (NAFLD) among U.S. adults. NAFLD is considered a precursor to liver cancer, specifically HCC. If this condition is left untreated, it can progress to non-alcoholic steatohepatitis and lead to serious complications, like cirrhosis or liver cancer.
Both studies also confirm the findings of the Environmental Protection Agency (EPA) that PFAS exposure can increase the risk of developing certain forms of cancer. Because of their persistent nature, PFAS can stay in the body for a long time and have the tendency to accumulate in cells and organs, including the liver. Firefighters who have been constantly exposed to AFFF in training and emergency response are at risk of having higher levels of PFAS chemicals in their bodies, which may drastically affect cancer risks.
ELG Law can help you file your AFFF liver cancer claim
We've worked with victims of toxic exposure claims for over 35 years. If you are a civilian or military firefighter with liver cancer and a history of AFFF exposure, you might be eligible for an AFFF exposure claim. Our attorneys can evaluate your documents and records to determine if you qualify. Contact ELG Law as soon as you can to schedule your free consultation (at no cost to you).